Table 3.
Common adverse events of clinical and laboratory abnormalities.
| Adverse event | Grade 1/2 | Grade 3/4 | Patients, n (%) | ||
|---|---|---|---|---|---|
| Chemotherapy | TKIs treatment | Chemotherapy | TKIs treatment | ||
| Non-hematologic | |||||
| Hypertension | 0 | 1 | 0 | 0 | 1 (4.5%) |
| Mucositis | 0 | 1 | 0 | 0 | 1 (4.5%) |
| Hypothyroidism | 1 | 2 | 0 | 1 | 4 (18.2%) |
| Fatigue | 1 | 2 | 0 | 0 | 1 (4.5%) |
| Diarrhea | 1 | 4 | 0 | 0 | 5 (22.7%) |
| Upper gastrointestinal bleeding | 0 | 0 | 0 | 1 | 1 (4.5%) |
| Hypophysitis | 1 | 1 | 0 | 0 | 2 (9.1%) |
| Anorexia | 3 | 3 | 0 | 0 | 6 (27.3%) |
| Albuminuria | 0 | 1 | 0 | 0 | 1 (4.5%) |
| Hyperbilirubinemia | 0 | 1 | 0 | 0 | 1 (4.5%) |
| Hematologic | |||||
| Hemoglobin | 0 | 0 | 0 | 1 | 1 (4.5%) |
| Leukocyte | 0 | 0 | 1 | 0 | 1 (4.5%) |
| Platelets | 0 | 0 | 1 | 0 | 1 (4.5%) |